These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

470 related items for PubMed ID: 8362983

  • 1. Atheromatous plaque macrophages produce plasminogen activator inhibitor type-1 and stimulate its production by endothelial cells and vascular smooth muscle cells.
    Tipping PG, Davenport P, Gallicchio M, Filonzi EL, Apostolopoulos J, Wojta J.
    Am J Pathol; 1993 Sep; 143(3):875-85. PubMed ID: 8362983
    [Abstract] [Full Text] [Related]

  • 2. Thrombin stimulates expression of tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in cultured human vascular smooth muscle cells.
    Wojta J, Gallicchio M, Zoellner H, Hufnagl P, Last K, Filonzi EL, Binder BR, Hamilton JA, McGrath K.
    Thromb Haemost; 1993 Sep 01; 70(3):469-74. PubMed ID: 8259551
    [Abstract] [Full Text] [Related]

  • 3. Enhanced tissue factor activity and plasminogen activator inhibitor-1 antigen in human umbilical vein endothelial cells incubated with lipoproteins.
    Kaneko T, Wada H, Wakita Y, Minamikawa K, Nakase T, Mori Y, Deguchi K, Shirakawa S.
    Blood Coagul Fibrinolysis; 1994 Jun 01; 5(3):385-92. PubMed ID: 8075310
    [Abstract] [Full Text] [Related]

  • 4. Enhancement by homocysteine of plasminogen activator inhibitor-1 gene expression and secretion from vascular endothelial and smooth muscle cells.
    Midorikawa S, Sanada H, Hashimoto S, Watanabe T.
    Biochem Biophys Res Commun; 2000 May 27; 272(1):182-5. PubMed ID: 10872824
    [Abstract] [Full Text] [Related]

  • 5. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis.
    Jung HS, Park KH, Cho YM, Chung SS, Cho HJ, Cho SY, Kim SJ, Kim SY, Lee HK, Park KS.
    Cardiovasc Res; 2006 Jan 27; 69(1):76-85. PubMed ID: 16271710
    [Abstract] [Full Text] [Related]

  • 6. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls.
    Chomiki N, Henry M, Alessi MC, Anfosso F, Juhan-Vague I.
    Thromb Haemost; 1994 Jul 27; 72(1):44-53. PubMed ID: 7974374
    [Abstract] [Full Text] [Related]

  • 7. [Effect of PAI-1 antisense RNA on vascular endothelial growth factor expression in aorta smooth muscle cells cultured in vitro].
    Fu L, Mei Y, Li H.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2001 Apr 27; 18(2):110-3. PubMed ID: 11295128
    [Abstract] [Full Text] [Related]

  • 8. Antifibrinolytic properties of the vascular wall. Dependence on the history of smooth muscle cell doublings in vitro and in vivo.
    Christ G, Hufnagl P, Kaun C, Mundigler G, Laufer G, Huber K, Wojta J, Binder BR.
    Arterioscler Thromb Vasc Biol; 1997 Apr 27; 17(4):723-30. PubMed ID: 9108786
    [Abstract] [Full Text] [Related]

  • 9. Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.
    Fukao H, Hagiya Y, Ueshima S, Okada K, Takaishi T, Izaki S, Matsuo O.
    Thromb Haemost; 1996 Feb 27; 75(2):352-8. PubMed ID: 8815589
    [Abstract] [Full Text] [Related]

  • 10. Growth inhibition of vascular smooth muscle cells derived from urokinase receptor (u-PAR)-deficient mice in the presence of carcinoma cells.
    Ueshima S, Fukao H, Okada K, Matsuo O.
    Thromb Res; 2004 Feb 27; 113(1):41-9. PubMed ID: 15081564
    [Abstract] [Full Text] [Related]

  • 11. Density-dependent endothelial cell production of an inhibitor of smooth muscle cell growth.
    Dodge AB, Lu X, D'Amore PA.
    J Cell Biochem; 1993 Sep 27; 53(1):21-31. PubMed ID: 8227180
    [Abstract] [Full Text] [Related]

  • 12. Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques.
    Tipping PG, Hancock WW.
    Am J Pathol; 1993 Jun 27; 142(6):1721-8. PubMed ID: 8506944
    [Abstract] [Full Text] [Related]

  • 13. Plasminogen activator inhibitor-1 deficiency enhances flow-induced smooth muscle cell migration.
    Cullen JP, Nicholl SM, Sayeed S, Sitzmann JV, Okada SS, Cahill PA, Redmond EM.
    Thromb Res; 2004 Jun 27; 114(1):57-65. PubMed ID: 15262486
    [Abstract] [Full Text] [Related]

  • 14. Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
    Nordt TK, Lutzi S, Ruef J, Peter K, Klar E, Kübler W, Sobel BE, Bode C.
    Thromb Haemost; 2001 Nov 27; 86(5):1305-13. PubMed ID: 11816722
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.
    Blei F, Wilson EL, Mignatti P, Rifkin DB.
    J Cell Physiol; 1993 Jun 27; 155(3):568-78. PubMed ID: 7684043
    [Abstract] [Full Text] [Related]

  • 16. Release of soluble urokinase receptor from vascular cells.
    Chavakis T, Willuweit AK, Lupu F, Preissner KT, Kanse SM.
    Thromb Haemost; 2001 Aug 27; 86(2):686-93. PubMed ID: 11522023
    [Abstract] [Full Text] [Related]

  • 17. In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
    Dichtl W, Ares MP, Stollenwerk M, Giachelli CM, Scatena M, Hamsten A, Eriksson P, Nilsson J.
    Thromb Haemost; 2000 Oct 27; 84(4):706-11. PubMed ID: 11057874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.